Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000775278 | SCV000909537 | likely benign | Familial hypercholesterolemia | 2018-09-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001078971 | SCV001006652 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-08-24 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000865650 | SCV001134561 | likely benign | not provided | 2019-05-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002388398 | SCV002673832 | likely benign | Cardiovascular phenotype | 2020-06-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV001078971 | SCV004836408 | likely benign | Hypercholesterolemia, autosomal dominant, 3 | 2023-12-01 | criteria provided, single submitter | clinical testing | |
GENin |
RCV000775278 | SCV005441507 | likely benign | Familial hypercholesterolemia | 2023-07-25 | criteria provided, single submitter | clinical testing | This is a synonymous (silent) variant that is not predicted by SpliceAI to impact splicing. In addition, it occurs at a nucleotide that is not conserved. Therefore this variant has been classified as Likely Benign (BP4, BP7). |